Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arrowhead Pharmaceuticals (ARWR) Return on Invested Capital (2018 - 2025)

Historic Return on Invested Capital for Arrowhead Pharmaceuticals (ARWR) over the last 7 years, with Q4 2025 value amounting to 0.48%.

  • Arrowhead Pharmaceuticals' Return on Invested Capital rose 55200.0% to 0.48% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.48%, marking a year-over-year increase of 55200.0%. This contributed to the annual value of 0.16% for FY2025, which is 26600.0% up from last year.
  • Arrowhead Pharmaceuticals' Return on Invested Capital amounted to 0.48% in Q4 2025, which was up 55200.0% from 0.1% recorded in Q3 2025.
  • Arrowhead Pharmaceuticals' 5-year Return on Invested Capital high stood at 0.48% for Q4 2025, and its period low was 5.04% during Q4 2024.
  • Over the past 5 years, Arrowhead Pharmaceuticals' median Return on Invested Capital value was 0.4% (recorded in 2022), while the average stood at 0.8%.
  • Per our database at Business Quant, Arrowhead Pharmaceuticals' Return on Invested Capital tumbled by -37400bps in 2024 and then soared by 55200bps in 2025.
  • Arrowhead Pharmaceuticals' Return on Invested Capital (Quarter) stood at 0.48% in 2021, then increased by 18bps to 0.4% in 2022, then tumbled by -228bps to 1.3% in 2023, then crashed by -288bps to 5.04% in 2024, then soared by 109bps to 0.48% in 2025.
  • Its Return on Invested Capital was 0.48% in Q4 2025, compared to 0.1% in Q3 2025 and 0.17% in Q2 2025.